Bristol-Myers Squibb Co. and Asterand PLC are extending a research partnership for up to three years.
With offices in Detroit and the United Kingdom, Asterand will continue to provide drug discovery services, human tissue and clinical samples to drugmaker Bristol-Myers Squibb that will, in turn, use the tissue and samples in research on potential drugs.
The companies, which entered into a three-year partnership in May 2007, did not disclose the financial terms.
Shares of Bristol-Myers rose 26 cents to $24.72 in morning trading.
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
Sign up for a free one-year subscription to EQUITIES Magazine
